Beam Therapeutics Inc.
BEAM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745999
In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 1 sale; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
Q2 2023 vs. Q1 2023
How the institutions holding Beam Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 207 | 1 | 194 | −12 |
| Shares | 60.4M | 500 | 64.2M | +3.83M (+6.3%) |
| Value | $1.85B | $15.3K | $2.05B | +$201.1M (+10.9%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Beam Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 195,000 | $6.23M | 0.13% |
| Contrarius Investment Management Ltd | 113,364 | $3.62M | 0.19% |
| Jump Financial, LLC | 27,225 | $869.3K | 0.03% |
| Harbor Capital Advisors, Inc. | 26,119 | $834.0K | 0.17% |
| Corton Capital Inc. | 10,687 | $341.2K | 0.16% |
| Ameriprise Financial Inc | 9,473 | $302.5K | 0.00% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 7,931 | $253.2K | 0.00% |
| Kraematon Investment Advisors, Inc | 7,915 | $252.7K | 0.28% |
| SEI Investments Co | 7,142 | $228.0K | 0.00% |
| Tudor Investment Corp Et Al | 6,821 | $217.8K | 0.00% |
| Cornercap Investment Counsel Inc | 6,655 | $212.5K | 0.04% |
| Quantbot Technologies LP | 3,400 | $108.6K | 0.01% |
| Riverview Trust Co | 390 | $12.5K | 0.01% |
| Retirement Group, LLC | 160 | $5.11K | 0.00% |
| Versant Capital Management, Inc | 105 | $3.35K | 0.00% |
| Salem Investment Counselors Inc | 35 | $1.12K | 0.00% |
| Baker Avenue Asset Management, LP | 23 | $734 | 0.00% |
| Glassman Wealth Services | 5 | $160 | 0.00% |
| Sofos Investments, Inc. | 32 | $31 | 0.00% |
Sold out (31)
Institutions that held Beam Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (1)
Institutions that held Beam Therapeutics Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Ahrens Investment Partners LLC | 500 | $15.3K |